Alfa Wassermann Diagnostic Technologies is a prominent player in the medical diagnostic instrumentation and reagents sector with a strong commitment to reliability and efficiency. The company's slogan, "When Every Moment Counts, You Can Count On Us," encapsulates its dedication to delivering timely and accurate solutions. Founded in 1960, the company has established a global presence, catering to diverse markets including physician offices, veterinary labs, and biopharmaceutical facilities. Alfa Wassermann's ACE Alera, ACE Axcel, and Vet Axcel clinical chemistry analyzers are renowned products, garnering attention from physicians, veterinarians, research laboratories, pharmaceutical companies, academic institutions, and animal conservatories. With a track record of 18 consecutive years of award-winning customer satisfaction, the company prides itself on providing high-quality service and support. Alfa Wassermann's commitment to customer satisfaction has been a key driver in its success and growth. While specific details on the company's headquarter, last investment, and last investment investors are not publicly available, its continual innovation and dedication to customer-centric solutions position it as a promising investment opportunity within the Biotechnology and Manufacturing industries. For more information about Alfa Wassermann Diagnostic Technologies, visitors can explore the company's website at www.AlfaWassermannUS.com.
There is no investment information
No recent news or press coverage available for Alfa Wassermann Diagnostic Technologies.